Human prothrombin complex concentrate (Shanxi Kangbao Biological Products)

人凝血酶原复合物(山西康宝生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex concentrate (Shanxi Kangbao Biological Products)
Drug Alias NameN/A
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryMainland China
Original Approved Date2019/09/17
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanxi Kangbao Biological Product Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanxi Kangbao Biological Product Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsHemophilia B

Other Information

ATC CodeB02BD01
Related LinksWikipediaDrugBankKEGG